Abstract
Since carcinogenesis is a multi-stage, multi-mechanism process, involving mutagenic, cell death and epigenetic mechanisms, during the "initiation/promotion/and progression" phases, chemoprevention must be based on understanding the mechanism(s) of each phase. Prevention of each phase could reduce the risk to cancer. Because reducing the initiation phase to a zero level is impossible, the most effective intervention would be at the promotion phase. Assuming the "target" cells for carcinogenesis are the pluri-potent stem cells and their early progenitor or transit cells, chemoprevention strategies for inhibiting the promotion of these two types of pre-malignant "initiated" cells will require different agents. A hypothesis will be proposed that involves stem cells, which lack gap junctional intercellular communication (GJIC-) or their early progenitor daughter cells, which express GJIC+ and are partially-differentiated, if initiated, will be promoted by agents that either inhibit secreted negative growth regulators or by inhibitors of GJIC. Chemopreventing agents to each of these two types of initiated cells must have different mechanisms of action. Assuming stem cells are target cells for carcinogenesis, an alternative method of ...Continue Reading
References
Jul 14, 1966·Annals of the New York Academy of Sciences·W R Loewenstein
Aug 18, 1983·Nature·H LandR A Weinberg
Jan 1, 1981·Journal of Supramolecular Structure and Cellular Biochemistry·H C PitotS Moran
Mar 1, 1995·Carcinogenesis·C Y KaoC C Chang
Feb 1, 1997·Carcinogenesis·K S KangC C Chang
Apr 1, 1997·In Vitro Cellular & Developmental Biology. Animal·C Y KaoC C Chang
Sep 1, 1997·Current Biology : CB·A TemmeK Willecke
Nov 6, 1998·Science·J A ThomsonJ M Jones
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·M J ShamblottJ D Gearhart
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Feb 5, 2000·Carcinogenesis·T J KingJ S Bertram
Aug 30, 2000·Carcinogenesis·K SaiT Inoue
Dec 20, 2000·Radiation Research·C C ChangJ E Trosko
Jul 20, 2002·Molecular Membrane Biology·W Howard Evans, Patricia E M Martin
Mar 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·John E Dick
Dec 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yi LiHarold E Varmus
Apr 20, 2004·Cardiovascular Research·Goran Söhl, Klaus Willecke
Citations
Nov 13, 2008·Cytotechnology·Finbarr O'Sullivan, Martin Clynes
Apr 22, 2008·Stem Cell Reviews·James E Trosko
Apr 20, 2013·Neuropharmacology·Vytas K Verselis, Miduturu Srinivas
Jun 26, 2008·PloS One·Kelly E CorcoranPranela Rameshwar
Dec 17, 2015·Expert Opinion on Therapeutic Targets·Sajid KhanSyed Musthapa Meeran
Mar 25, 2008·Cancer Letters·Pranav K ChaturvediYogeshwer Shukla
Feb 6, 2009·International Journal of Cancer. Journal International Du Cancer·Joice Kuroiwa-TrzmielinaFernando Salvador Moreno
Jun 15, 2007·Chemico-biological Interactions·Fernando Salvador MorenoThomas Prates Ong
Jul 17, 2012·Cell Adhesion & Migration·James S HaleJustin D Lathia
Mar 28, 2012·Biochimica Et Biophysica Acta·T Harshani Peiris, Néstor J Oviedo
Jun 9, 2016·Nutrition and Cancer·Pavel BabicaBrad L Upham
Sep 24, 2011·The Journal of Nutritional Biochemistry·Aline de ContiFernando S Moreno
Mar 6, 2009·Veterinary Pathology·J E Trosko
Jul 5, 2019·International Journal of Molecular Sciences·Antonella LeoneJames E Trosko
Jun 7, 2016·Developmental Neurobiology·Juanita Mathews, Michael Levin
Oct 4, 2018·Cancers·Sanjeevani AroraSteve M Patrick
May 8, 2007·Progress in Biophysics and Molecular Biology·Michael Levin
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Deepika Soni, Abhinav Grover
May 4, 2010·The Journal of Nutritional Biochemistry·Mônica Testoni CardozoFernando Salvador Moreno